Journal of Clinical Pediatrics >
Analysis of the results of newborn screening for fatty acid oxidative metabolic diseases in ethnic minority areas of Hainan Province
Received date: 2022-09-05
Online published: 2024-02-02
Objective To investigate the incidence of fatty acid oxidative metabolism disorders (FAOD) in the neonatal population in ethnic minority areas of Hainan Province, and to analyse the clinical characteristics of the diagnosed children, so as to provide the basis for the prevention of birth defects in Hainan Province. Methods Tandem mass spectrometry screening data of newborns with inherited metabolic disorders from October 2016 to December 2021 were collected from ethnic minority areas in Hainan Province. Tandem mass spectrometry was used to detect the levels of free carnitine as well as 30 acylcarnitines in dried blood spots of newborns. Initial screen-positive neonates were recalled for review of blood tandem mass spectrometry, urinary organic acids were measured by gas-phase mass spectrometry, and peripheral blood was collected from neonates and their parents for gene sequencing. Results A total of 46285 newborn samples were screened, of which 513 were positive in the first screening, the positive rate of the first screening was 1/90, 501 cases were recalled, and 11 cases of fatty acid β -oxidation metabolic disease were diagnosed, the incidence rate was 1/4208, including 6 cases of primary carnitine deficiency, 1 case of short chain, medium chain and very long acyl-CoA dehydrogenase deficiency, and 1 case of carnitine palmitoyl transferase I and II deficiency. Conclusion The incidence of fatty acid β-oxidative metabolic disease is high among newborns in minority areas of Hainan province, and primary carnitine deficiency is more common. It is suggested that the screening of neonatal genetic metabolic diseases by tandem mass spectrometry should be included in the routine of newborn screening program.
Cidan HUANG , Haizhu XU , Yingmei WEN , Xiulian LIU . Analysis of the results of newborn screening for fatty acid oxidative metabolic diseases in ethnic minority areas of Hainan Province[J]. Journal of Clinical Pediatrics, 2024 , 42(2) : 133 -138 . DOI: 10.12372/jcp.2024.22e1193
[1] | El-Gharbawy A, Jerry V. Inborn errors of metabolism with myopathy: defects of fatty acid oxidation and the carnitine shuttle system[J]. Pediatr Clin North Am, 2018, 65(2): 317-335. |
[2] | Touati G, Gorce M, Oliver-Petit I, et al. New inborn errors of metabolism added in the French program of neonatal screening[J]. Med Sci (Paris), 2021, 37(5): 507-518. |
[3] | Kapoor S, Thelma BK. Status of newborn screening and inborn errors of metabolism in India[J]. Indian J Pediatr, 2018, 85(12): 1110-1117. |
[4] | Zhang R, Qiang R, Song C, et al. Spectrum analysis of inborn errors of metabolism for expanded newborn screening in a northwestern Chinese population[J]. Sci Rep, 2021, 11(1): 2699. |
[5] | Longo N, Frigeni M, Pasquali M. Carnitine transport and fatty acid oxidation[J]. Biochim Biophys Acta, 2016, 1863(10): 2422-2435. |
[6] | 赵振东, 王洁, 谢曼芳, 等. 海南省少数民族自治市县原发性肉碱缺乏症筛查分析[J]. 中华检验医学杂志, 2019(4): 293-296. |
[7] | 温英梅, 赵振东, 王洁. 海南省黎族新生儿原发性肉碱缺乏症筛查及基因情况分析[J]. 中国全科医学, 2020, 23(18): 2299-2303. |
[8] | Ferreira CR, Rahman S, Keller M, et al. An international classification of inherited metabolic disorders (ICIMD)[J]. J Inherit Metab Dis, 2021, 44(1): 164-177. |
[9] | Burlina AB, Polo G, Salviati L, et al. Newborn screening for lysosomal storage disorders by tandem mass spectrometry in North East Italy[J]. J Inherit Metab Dis, 2018, 41(2): 209-219. |
[10] | Frigeni M, Balakrishnan B, Yin X, et al. Functional and molecular studies in primary carnitine deficiency[J]. Hum Mutat, 2017, 38(12): 1684-1699. |
[11] | Lin W, Wang K, Zheng Z, et al. Newborn screening for primary carnitine deficiency in Quanzhou, China[J]. Clin Chim Acta, 2021, 512: 166-171. |
[12] | Nowinski SM, Solmonson A, Rusin SF, et al. Mitochondrial fatty acid synthesis coordinates oxidative metabolism in mammalian mitochondria[J]. Elife, 2020, 9: e58041. |
[13] | Raud B, McGuire PJ, Jones RG, et al. Fatty acid metabolism in CD8+ T cell memory: challenging current concepts[J]. Immunol Rev, 2018, 283(1): 213-231. |
[14] | Wilcken B, Wiley V, Hammond J, et al. Screening newborns for inborn errors of metabolism by tandem mass spectrometry[J]. N Engl J Med, 2003, 348(23): 2304-2312. |
[15] | Feuchtbaum L, Carter J, Dowray S, et al. Birth prevalence of disorders detectable through newborn screening by race/ethnicity[J]. Genet Med, 2012, 14(11): 937-945. |
[16] | Lindner M, Gramer G, Haege G, et al. Efficacy and outcome of expanded newborn screening for metabolic diseases--report of 10 years from South-West Germany[J]. Orphanet J Rare Dis, 2011, 6: 44. |
[17] | la Marca G, Malvagia S, Casetta B, et al. Progress in expanded newborn screening for metabolic conditions by LC-MS/MS in Tuscany: update on methods to reduce false tests[J]. J Inherit Metab Dis, 2008, 31 (Suppl 2): S395-S404. |
[18] | Zhao Z, Chen C, Sun XS, et al. Newborn screening for inherited metabolic diseases using tandem mass spectrometry in China: outcome and cost-utility analysis[J]. J Med Screen, 2022, 29(1): 12-20. |
[19] | Sun F, Zhang JX, Yang CY, et al. The genetic characteristics of congenital hypothyroidism in China by comprehensive screening of 21 candidate genes[J]. Eur J Endocrinol, 2018, 178(6): 623-633. |
[20] | Koizumi A, Nozaki J, Ohura T, et al. Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency[J]. Hum Mol Genet, 1999, 8: 2247-2254. |
[21] | Wilcken B, Wiley V, Sim KG, et al. Carnitine transporter defect diagnosed by newborn screening with electrospray tandem mass spectrometry[J]. J Pediatr, 2001, 138: 581-584. |
[22] | Echaniz-Laguna A, Biancalana V, Gaignard P, et al. Primary carnitine deficiency in a 57-year-old patient with recurrent exertional rhabdomyolysis[J]. BMJ Case Rep, 2018, 2018: bcr2018224272. |
[23] | Jakoby M 4th, Jaju A, Marsh A, et al. Maternal primary carnitine deficiency and a novel solute carrier family 22 member 5 (SLC22A5) mutation[J]. J Investig Med High Impact Case Rep, 2021, 9: 23247096211019543. |
[24] | Lin Y, Zhang W, Huang C, et al. Increased detection of primary carnitine deficiency through second-tier newborn genetic screening[J]. Orphanet J Rare Dis, 2021, 16(1): 149. |
[25] | Wang H, Wang X, Li Y, et al. Screening for inherited metabolic diseases using gas chromatography-tandem mass spectrometry (GC-MS/MS) in Sichuan, China[J]. Biomed Chromatogr, 2017, 31(4). |
[26] | Yang Q, Xu L, Tang LJ, et al. Simultaneous detection of multiple inherited metabolic diseases using GC-MS urinary metabolomics by chemometrics multi-class classification strategies[J]. Talanta, 2018, 186: 489-496. |
[27] | 杨池菊, 史彩虹, 周成, 等. 山东省济宁地区新生儿脂肪酸氧化代谢病筛查及随访分析[J]. 浙江大学学报(医学版), 2021, 50(4): 472-480. |
/
〈 |
|
〉 |